Christopher R. LaPensee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christopher R. LaPensee has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Gary Douglas Hammer
Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, USA
16 shared publications - Alda Wakamatsu
13Departamento de Patologia, Faculdade de Medicina da Universidade de São Paulo, SP, Brazil
15 shared publications - Ana Claudia Latronico
Endocrinology & Metabolism Division, Laboratory of Hormones and Molecular Genetics (LIM42), Clinics Hospital, Medical School, University of Sao Paulo , Sao Paulo
15 shared publications - Antonio Marcondes Lerario
Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes University of Michigan Ann Arbor Michigan USA
15 shared publications - April A. Apfelbaum
Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children’s Research Institute
15 shared publications - April L. Solon
Department of Cell & Developmental Biology, University of Michigan, Ann Arbor, Michigan
15 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Information from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Information:Supplementary Figures 1-6 with Figure Legends, Supplementary Table 1 (reference only), Supplementary Table 2, Supplementary Methods, Supplementary References
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Information from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Information:Supplementary Figures 1-6 with Figure Legends, Supplementary Table 1 (reference only), Supplementary Table 2, Supplementary Methods, Supplementary References
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Information from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
Supplementary Information: Supplementary Figures 1-6 with Figure Legends, Supplementary Table 1 (reference only), Supplementary Table 2, Supplementary Methods, Supplementary References
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Information from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
Supplementary Information: Supplementary Figures 1-6 with Figure Legends, Supplementary Table 1 (reference only), Supplementary Table 2, Supplementary Methods, Supplementary References
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Information from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
Supplementary Information: Supplementary Figures 1-6 with Figure Legends, Supplementary Table 1 (reference only), Supplementary Table 2, Supplementary Methods, Supplementary References
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Information from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
Supplementary Information: Supplementary Figures 1-6 with Figure Legends, Supplementary Table 1 (reference only), Supplementary Table 2, Supplementary Methods, Supplementary References
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from β-catenin-driven differentiation is a tissue-specific epigenetic vulnerability in adrenal cancer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.
- Open Access
- 5 July 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Information from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Information:Supplementary Figures 1-6 with Figure Legends, Supplementary Table 1 (reference only), Supplementary Table 2, Supplementary Methods, Supplementary References
- 5 July 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Information from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Information:Supplementary Figures 1-6 with Figure Legends, Supplementary Table 1 (reference only), Supplementary Table 2, Supplementary Methods, Supplementary References
- Open Access
- 5 July 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Information from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Information:Supplementary Figures 1-6 with Figure Legends, Supplementary Table 1 (reference only), Supplementary Table 2, Supplementary Methods, Supplementary References
- 5 July 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Information from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Information:Supplementary Figures 1-6 with Figure Legends, Supplementary Table 1 (reference only), Supplementary Table 2, Supplementary Methods, Supplementary References
- Open Access
- 5 July 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.
- 5 July 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.
- Open Access
- 5 July 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.
- 5 July 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Supplementary Table 1: NCI-H295R RNA-seq FPKM table, Related to Figures 2-4, 6.